Form 4: Dorman Products SVP, Sales and Marketing, Jeffery Darby, Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Jeffery Darby, SVP of Sales and Marketing at Dorman Products, reports the acquisition of 1,854 shares and disposition of 849 shares of common stock on February 20, 2025.

Summary

  • On February 20, 2025, Jeffery Darby, SVP of Sales and Marketing at Dorman Products, engaged in transactions involving the company's common stock.
  • He acquired 1,854 shares through the settlement of performance-based restricted stock units granted in fiscal year 2022 for the 2022-2024 performance cycle.
  • Additionally, he disposed of 849 shares to cover tax withholding obligations related to the vesting of restricted stock units at a price of $126.49 per share.
  • Following these transactions, Darby directly owns 17,290 shares of Dorman Products common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect routine executive compensation adjustments.

Key Dates

DateDescription
02/20/2025Date of stock acquisition and disposition.
02/24/2025Date of signature on the Form 4 filing.

Keywords

Dorman Products, Jeffery Darby, Stock Transactions, Form 4, Beneficial Ownership, Restricted Stock Units, Tax Withholding, DORM

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.